ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.37 USD 1.48% Market Closed
Market Cap: 229.9m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

Intrinsic Value

ATAI's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ATAI stock under the Base Case scenario is 2.07 USD. Compared to the current market price of 1.37 USD, ATAI Life Sciences NV is Undervalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ATAI Intrinsic Value
2.07 USD
Undervaluation 34%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
ATAI Life Sciences NV

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ATAI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ATAI?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about ATAI Life Sciences NV

Provide an overview of the primary business activities
of ATAI Life Sciences NV.

What unique competitive advantages
does ATAI Life Sciences NV hold over its rivals?

What risks and challenges
does ATAI Life Sciences NV face in the near future?

Has there been any significant insider trading activity
in ATAI Life Sciences NV recently?

Summarize the latest earnings call
of ATAI Life Sciences NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ATAI Life Sciences NV.

Provide P/S
for ATAI Life Sciences NV.

Provide P/E
for ATAI Life Sciences NV.

Provide P/OCF
for ATAI Life Sciences NV.

Provide P/FCFE
for ATAI Life Sciences NV.

Provide P/B
for ATAI Life Sciences NV.

Provide EV/S
for ATAI Life Sciences NV.

Provide EV/GP
for ATAI Life Sciences NV.

Provide EV/EBITDA
for ATAI Life Sciences NV.

Provide EV/EBIT
for ATAI Life Sciences NV.

Provide EV/OCF
for ATAI Life Sciences NV.

Provide EV/FCFF
for ATAI Life Sciences NV.

Provide EV/IC
for ATAI Life Sciences NV.

Show me price targets
for ATAI Life Sciences NV made by professional analysts.

What are the Revenue projections
for ATAI Life Sciences NV?

How accurate were the past Revenue estimates
for ATAI Life Sciences NV?

What are the Net Income projections
for ATAI Life Sciences NV?

How accurate were the past Net Income estimates
for ATAI Life Sciences NV?

What are the EPS projections
for ATAI Life Sciences NV?

How accurate were the past EPS estimates
for ATAI Life Sciences NV?

What are the EBIT projections
for ATAI Life Sciences NV?

How accurate were the past EBIT estimates
for ATAI Life Sciences NV?

Compare the revenue forecasts
for ATAI Life Sciences NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ATAI Life Sciences NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ATAI Life Sciences NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of ATAI Life Sciences NV compared to its peers.

Compare the P/E ratios
of ATAI Life Sciences NV against its peers.

Discuss the investment returns and shareholder value creation
comparing ATAI Life Sciences NV with its peers.

Analyze the financial leverage
of ATAI Life Sciences NV compared to its main competitors.

Show all profitability ratios
for ATAI Life Sciences NV.

Provide ROE
for ATAI Life Sciences NV.

Provide ROA
for ATAI Life Sciences NV.

Provide ROIC
for ATAI Life Sciences NV.

Provide ROCE
for ATAI Life Sciences NV.

Provide Gross Margin
for ATAI Life Sciences NV.

Provide Operating Margin
for ATAI Life Sciences NV.

Provide Net Margin
for ATAI Life Sciences NV.

Provide FCF Margin
for ATAI Life Sciences NV.

Show all solvency ratios
for ATAI Life Sciences NV.

Provide D/E Ratio
for ATAI Life Sciences NV.

Provide D/A Ratio
for ATAI Life Sciences NV.

Provide Interest Coverage Ratio
for ATAI Life Sciences NV.

Provide Altman Z-Score Ratio
for ATAI Life Sciences NV.

Provide Quick Ratio
for ATAI Life Sciences NV.

Provide Current Ratio
for ATAI Life Sciences NV.

Provide Cash Ratio
for ATAI Life Sciences NV.

What is the historical Revenue growth
over the last 5 years for ATAI Life Sciences NV?

What is the historical Net Income growth
over the last 5 years for ATAI Life Sciences NV?

What is the current Free Cash Flow
of ATAI Life Sciences NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for ATAI Life Sciences NV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ATAI Life Sciences NV

Current Assets 117.9m
Cash & Short-Term Investments 88.3m
Receivables 12.1m
Other Current Assets 17.5m
Non-Current Assets 97.9m
Long-Term Investments 93.5m
PP&E 1.9m
Other Non-Current Assets 2.4m
Current Liabilities 17.6m
Accounts Payable 3.8m
Accrued Liabilities 12.8m
Other Current Liabilities 1m
Non-Current Liabilities 30.2m
Long-Term Debt 18.6m
Other Non-Current Liabilities 11.7m
Efficiency

Earnings Waterfall
ATAI Life Sciences NV

Revenue
381k USD
Operating Expenses
-111.5m USD
Operating Income
-111.2m USD
Other Expenses
53.1m USD
Net Income
-58.1m USD

Free Cash Flow Analysis
ATAI Life Sciences NV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ATAI Profitability Score
Profitability Due Diligence

ATAI Life Sciences NV's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
ROIC is Increasing
Exceptional 1-Year Revenue Growth
ROE is Increasing
22/100
Profitability
Score

ATAI Life Sciences NV's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

ATAI Solvency Score
Solvency Due Diligence

ATAI Life Sciences NV's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
55/100
Solvency
Score

ATAI Life Sciences NV's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ATAI Price Targets Summary
ATAI Life Sciences NV

There are no price targets for ATAI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ATAI?

Click here to dive deeper.

Dividends

ATAI Life Sciences NV
does not pay dividends
Shareholder Yield

Current shareholder yield for ATAI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ATAI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

ATAI News

Other Videos

Profile

ATAI Life Sciences NV Logo
ATAI Life Sciences NV

Country

Germany

Industry

Pharmaceuticals

Market Cap

229.8m USD

Dividend Yield

0%

Description

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.

Contact

BERLIN
Berlin
c/o Mindspace, Krausenstrasse 9-10
+498921539035.0
www.atai.life

IPO

2021-06-18

Employees

81

Officers

Founder & Chairman of the Supervisory Board
Mr. Christian Angermayer
Co-Founder & Co-CEO
Dr. Srinivas G. Rao M.D., Ph.D.
Co-Founder, MD & Co-CEO
Mr. Florian Brand
Chief Financial Officer
Ms. Anne Johnson
Senior Vice President of Operations
Dr. Michael Raven Ph.D.
Vice President of Investment & Venture Management
Mr. Frank Stegert
Show More
Senior VP, General Counsel & Corporate Secretary
Mr. Ryan Barrett
Senior Vice President of Early Development
Dr. Glenn Short Ph.D.
Chief Business Officer
Dr. Sahil V. Kirpekar M.D.
Senior Vice President of Clinical Development
Dr. Kevin Craig M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one ATAI stock?

The intrinsic value of one ATAI stock under the Base Case scenario is 2.07 USD.

Is ATAI stock undervalued or overvalued?

Compared to the current market price of 1.37 USD, ATAI Life Sciences NV is Undervalued by 34%.

Back to Top